Sangamo Therapeutics Inc (NASDAQ:SGMO)

19.05
Delayed Data
As of Apr 20
 -0.15 / -0.78%
Today’s Change
4.05
Today|||52-Week Range
27.50
+16.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues3.4M8.3M11.8M13.1M
 
 
 
 
 
Depreciation And Amortization301.0K317.0K412.0K468.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses19.9M20.7M24.4M26.4M
 
 
 
 
 
Research And Development12.9M15.0M18.4M19.4M
 
 
 
 
 
Total Operating Expenses20.2M21.0M24.8M26.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.8M-12.8M-13.0M-13.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.6M-12.5M-12.4M-13.1M
 
 
 
 
 
Net Income-16.6M-12.5M-12.4M-13.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.0M72.5M83.8M84.8M
 
 
 
 
 
Shares To Calculate EPS Diluted71.0M72.5M83.8M84.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.17-$0.15-$0.15
 
 
 
 
 
EPS Diluted-$0.23-$0.17-$0.15-$0.15